330 related articles for article (PubMed ID: 23349632)
21. Identification and characterization of a novel hepatitis B virus pregenomic RNA encapsidation inhibitor.
Jo E; Ryu DK; König A; Park S; Cho Y; Park SH; Kim TH; Yoon SK; Ryu WS; Cechetto J; Windisch MP
Antiviral Res; 2020 Mar; 175():104709. PubMed ID: 31940474
[TBL] [Abstract][Full Text] [Related]
22. Efficient Inhibition of Hepatitis B Virus (HBV) Replication and cccDNA Formation by HBV Ribonuclease H Inhibitors during Infection.
Chauhan R; Li Q; Woodson ME; Gasonoo M; Meyers MJ; Tavis JE
Antimicrob Agents Chemother; 2021 Nov; 65(12):e0146021. PubMed ID: 34516242
[TBL] [Abstract][Full Text] [Related]
23. Latest developments in the treatment of hepatitis B.
Dandri M; Petersen J
Minerva Gastroenterol Dietol; 2016 Mar; 62(1):88-102. PubMed ID: 26448309
[TBL] [Abstract][Full Text] [Related]
24. Ongoing viral replication and production of infectious virus in patients with chronic hepatitis B virus suppressed below the limit of quantitation on long-term nucleos(t)ide therapy.
Burdette DL; Lazerwith S; Yang J; Chan HLY; Delaney Iv WE; Fletcher SP; Cihlar T; Feierbach B
PLoS One; 2022; 17(4):e0262516. PubMed ID: 35363817
[TBL] [Abstract][Full Text] [Related]
25. 3-Hydroxypyrimidine-2,4-Diones as Novel Hepatitis B Virus Antivirals Targeting the Viral Ribonuclease H.
Huber AD; Michailidis E; Tang J; Puray-Chavez MN; Boftsi M; Wolf JJ; Boschert KN; Sheridan MA; Leslie MD; Kirby KA; Singh K; Mitsuya H; Parniak MA; Wang Z; Sarafianos SG
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28320718
[TBL] [Abstract][Full Text] [Related]
26. Complementation of Wild-Type and Drug-Resistant Hepatitis B Virus Genomes to Maintain Viral Replication and Rescue Virion Production under Nucleos(t)ide Analogs.
Wu C; Li B; Zhang X; Zhao K; Chen Y; Yuan Y; Liu Y; Chen R; Xu D; Chen X; Lu M
Virol Sin; 2019 Aug; 34(4):377-385. PubMed ID: 31218588
[TBL] [Abstract][Full Text] [Related]
27. Influence of the basal core promoter and precore mutation on replication of hepatitis B virus and antiviral susceptibility of different genotypes.
Cui XJ; Cho YK; Song BC
J Med Virol; 2015 Apr; 87(4):601-8. PubMed ID: 25612255
[TBL] [Abstract][Full Text] [Related]
28. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?
Sheldon J; Ramos B; Toro C; Ríos P; Martínez-Alarcón J; Bottecchia M; Romero M; Garcia-Samaniego J; Soriano V
Antivir Ther; 2008; 13(1):97-102. PubMed ID: 18389903
[TBL] [Abstract][Full Text] [Related]
29. Phosphorothioate di- and trinucleotides as a novel class of anti-hepatitis B virus agents.
Iyer RP; Jin Y; Roland A; Morrey JD; Mounir S; Korba B
Antimicrob Agents Chemother; 2004 Jun; 48(6):2199-205. PubMed ID: 15155222
[TBL] [Abstract][Full Text] [Related]
30. Synergistic Interactions between Hepatitis B Virus RNase H Antagonists and Other Inhibitors.
Lomonosova E; Zlotnick A; Tavis JE
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27956427
[TBL] [Abstract][Full Text] [Related]
31. Discovery of dihydroxyindole-2-carboxylic acid derivatives as dual allosteric HIV-1 Integrase and Reverse Transcriptase associated Ribonuclease H inhibitors.
Esposito F; Sechi M; Pala N; Sanna A; Koneru PC; Kvaratskhelia M; Naesens L; Corona A; Grandi N; di Santo R; D'Amore VM; Di Leva FS; Novellino E; Cosconati S; Tramontano E
Antiviral Res; 2020 Feb; 174():104671. PubMed ID: 31812637
[TBL] [Abstract][Full Text] [Related]
32. Magnesium chelating 2-hydroxyisoquinoline-1,3(2H,4H)-diones, as inhibitors of HIV-1 integrase and/or the HIV-1 reverse transcriptase ribonuclease H domain: discovery of a novel selective inhibitor of the ribonuclease H function.
Billamboz M; Bailly F; Lion C; Touati N; Vezin H; Calmels C; Andréola ML; Christ F; Debyser Z; Cotelle P
J Med Chem; 2011 Mar; 54(6):1812-24. PubMed ID: 21366258
[TBL] [Abstract][Full Text] [Related]
33. Heat stress cognate 70 host protein as a potential drug target against drug resistance in hepatitis B virus.
Wang YP; Liu F; He HW; Han YX; Peng ZG; Li BW; You XF; Song DQ; Li ZR; Yu LY; Cen S; Hong B; Sun CH; Zhao LX; Kreiswirth B; Perlin D; Shao RG; Jiang JD
Antimicrob Agents Chemother; 2010 May; 54(5):2070-7. PubMed ID: 20176893
[TBL] [Abstract][Full Text] [Related]
34. New antivirals for the treatment of chronic hepatitis B.
Soriano V; Barreiro P; Benitez L; Peña JM; de Mendoza C
Expert Opin Investig Drugs; 2017 Jul; 26(7):843-851. PubMed ID: 28521532
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis B virus reverse transcriptase - Target of current antiviral therapy and future drug development.
Clark DN; Hu J
Antiviral Res; 2015 Nov; 123():132-7. PubMed ID: 26408354
[TBL] [Abstract][Full Text] [Related]
36. Shedding light on RNaseH: a promising target for hepatitis B virus (HBV).
Edwards TC; Ponzar NL; Tavis JE
Expert Opin Ther Targets; 2019 Jul; 23(7):559-563. PubMed ID: 31084514
[No Abstract] [Full Text] [Related]
37. Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues.
Boni C; Laccabue D; Lampertico P; Giuberti T; Viganò M; Schivazappa S; Alfieri A; Pesci M; Gaeta GB; Brancaccio G; Colombo M; Missale G; Ferrari C
Gastroenterology; 2012 Oct; 143(4):963-73.e9. PubMed ID: 22796241
[TBL] [Abstract][Full Text] [Related]
38. Screening and Evaluation of Novel Compounds against Hepatitis B Virus Polymerase Using Highly Purified Reverse Transcriptase Domain.
Ohsaki E; Ueda K
Viruses; 2020 Jul; 12(8):. PubMed ID: 32752057
[TBL] [Abstract][Full Text] [Related]
39. Immune-driven adaptation of hepatitis B virus genotype D involves preferential alteration in B-cell epitopes and replicative attenuation--an insight from human immunodeficiency virus/hepatitis B virus coinfection.
Mondal RK; Khatun M; Ghosh S; Banerjee P; Datta S; Sarkar S; Saha B; Santra A; Banerjee S; Chowdhury A; Datta S
Clin Microbiol Infect; 2015 Jul; 21(7):710.e11-20. PubMed ID: 25882358
[TBL] [Abstract][Full Text] [Related]
40. Cutting into the Substrate Dominance: Pharmacophore and Structure-Based Approaches toward Inhibiting Human Immunodeficiency Virus Reverse Transcriptase-Associated Ribonuclease H.
Wang L; Sarafianos SG; Wang Z
Acc Chem Res; 2020 Jan; 53(1):218-230. PubMed ID: 31880912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
